Related Experiment Video

Updated: Aug 12, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumonia and empyema caused by Clostridium sordellii

T M File, R J Fass, R L Perkins

    The American Journal of the Medical Sciences
    |September 1, 1977
    PubMed

    Insights

    This report details the first case of pleuropulmonary infection caused by Clostridium sordellii. The infection presented acutely, mimicking pulmonary infarction, and responded well to penicillin and drainage.

    Area of Science:

    • Infectious Diseases
    • Bacteriology
    • Pulmonary Medicine

    Background:

    • Clostridium sordellii is a rare cause of human infection.
    • Pleuropulmonary infections are typically associated with other Clostridium species, such as Clostridium perfringens.
    • Understanding the clinical spectrum of C. sordellii infections is crucial for timely diagnosis and treatment.

    Observation:

    • A unique case of pleuropulmonary infection attributed to Clostridium sordellii is presented.
    • The patient exhibited an acute onset of symptoms, clinically resembling pulmonary infarction.
    • Key signs of toxicity, hemolysis, and shock were notably absent.

    Findings:

    • The clinical presentation of this C. sordellii infection was similar to pleuropulmonary infections caused by C. perfringens.
    • The patient demonstrated a positive response to antibiotic treatment with penicillin.
    • Surgical intervention, specifically drainage, was also a critical component of the successful management.

    Implications:

    • This case expands the known spectrum of diseases caused by Clostridium sordellii.
    • It highlights the importance of considering C. sordellii in the differential diagnosis of acute pleuropulmonary infections, especially when typical signs of severe toxicity are absent.
    • The similar clinical presentation and treatment response to C. perfringens infections suggest potential overlaps in management strategies.

    More Related Videos

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

    Published on: April 7, 2015

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

    Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

    Published on: June 15, 2019

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Chronic Obstructive Pulmonary Disease II: Emphysema01:23

    Chronic Obstructive Pulmonary Disease II: Emphysema

    Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...